An interventional study of Lidocaine IV and Lidocaine in Post Operative Pain, Hemodynamic Instability and Opioid Use, sponsored by Ankara University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-01-30.
Sponsored by Ankara University · Not applicable, Interventional, and Screening
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 117 studies testing lidocaine in Pain, Postoperative — 12 open to participants now, 15 under way, 5 of them phase 3. Lidocaine · Pain, Postoperative.
Among the 117 studies testing lidocaine in Pain, Postoperative, this one is the 52nd largest by planned enrollment, is one of 11 that started in 2023, is one of 41 with no phase, reaches primary completion later than 1 of the 14 other live ones, and was the 87th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →12 of the 117 studies testing lidocaine in Pain, Postoperative are open now, in 10 countries. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 18+ · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
King Edward Medical University · Sites in Pakistan
Ages 18–60
Sahiwal medical college sahiwal · Sites in Pakistan
Ages 20–70 · Healthy volunteers
E-DA Hospital · Sites in Taiwan
Ages 18–80
By country, each count listing its studies:
Lidocaine: first FDA approval 1948 (XYLOCAINE), first EMA approval 2013. What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
117 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 13 · Phase 3 24 · Phase 4 40
First in 2003; this study’s year is marked. 11 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 80 across the 117 interventional studies. Of the 80 that completed or were terminated, 11 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 117 have an industry lead sponsor. The 10 most frequent:
Ankara University is the lead sponsor of 323 studies on the registry; 65 are open to participants now.
15 studies in Pain, Postoperative by Ankara University: 3 open now, 4 under way, none of them phase 3. Of 9 finished, 1 (11%) have results posted.
Among the 15 studies in Pain, Postoperative by Ankara University, this one is the 6th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2023, is one of 11 with no phase, and was the 5th registered.
Ankara University’s Pain, Postoperative studies by the year they started, since 2009.
5 of the studies testing lidocaine in Pain, Postoperative that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07871266Phase 3Assiut UniversityEffect of Nebulized Lignocaine on Emergence Agitation After Sevoflurane Anesthesia in Pediatric Patients Undergoing Tonsillectomy | 2027-11 |
| NCT07488832Ankara City Hospital BilkentIntravenous Lidocaine Infusion in Lumbar Fusion Surgery | 2027-01-01 |
| NCT07068243Duke UniversityREctus Sheath Trial | 2027-02 |
| NCT07012889Medical University of WarsawIntraoperative Continuous Lidocaine Infusion in Laparoscopic Liver Surgery | 2027-03-02 |
| NCT06884540CHU de Quebec-Universite LavalOptimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial | 2027-04 |
Add all 5 to your calendar (.ics) → With an account.
Among the 117 studies testing lidocaine in Pain, Postoperative, from their registry updates:
Among Ankara University’s 15 in Pain, Postoperative:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to investigate the effects of intravenous infusion of lidocaine at different doses (1 mg/kg/h vs. 2 mg/kg/h) in the intraoperative period in patients undergoing lumbar stabilization, whether postoperative pain, postoperative opioid use, opioid-related side effects are reduced, and its effects on intraoperative hemodynamics
Lumbar stabilization surgery is among the surgical interventions with a high incidence of postoperative pain. Controlling postoperative pain and ensuring early recovery are important in terms of early neurological evaluation. It has been shown that lidocaine infusion administered during the intraoperative period causes peripheral vasodilation, synaptic transmission inhibition, and an increase in the depth of anesthesia. Because of these effects, the effects of lidocaine infusion on hemodynamic responses and recovery have been investigated. The safe dose range of lidocaine is 1-4 mg/kg, and the toxic dose is 5 mg/kg and above. Many studies have shown that lidocaine infusion suppresses the sympathetic reflex response and has a depressive effect on the cardiovascular system. In a study evaluating patients who underwent open radical prostatectomy surgery, it was found that blood pressure values were lower in patients who received intraoperative lidocaine infusion compared to the control group. In a study evaluating 60 female patients who underwent breast surgery, it was shown that the mean blood pressure value was significantly lower in patients who received lidocaine infusion. Lidocaine infusion has been applied at different doses (2-3 mg/kg/hour) and at different times in different surgical procedures, and it has been shown to be more effective in reducing postoperative pain, especially in some surgical procedures. Studies showing that lidocaine infusion provides early recovery in the perioperative period; They explain this effect of lidocaine by reducing the need for opioids and reducing the complications that affect the quality of recovery, such as opioid-related nausea and vomiting. It has been shown that 2 mg/kg/hour lidocaine infusion in patients undergoing vertebral surgery provides early and high-quality recovery by reducing the opioid requirement and reducing pain scores. In a study conducted in patients undergoing spinal fusion surgery, lidocaine was administered as a bolus of 2 mg/kg in the induction of anesthesia and infusion of 3 mg/kg/hour in the intraoperative period until the end of the surgery. Compared to the control group, the first additional analgesic need emerged later and the total amount of morphine consumption was found to be lower. Although there are studies in the literature using different doses of lidocaine in different surgeries, there are limited data on the effect of different doses of lidocaine on intraoperative postoperative pain and hemodynamics in patients who underwent vertebral surgery. In our study, we aimed to investigate the effect of different doses of lidocaine infusion (1 mg/kg/hour and 2 mg/kg/hour) on postoperative pain changes and hemodynamics. The main aim of the study is to evaluate whether 2 mg/kg/h lidocaine infusion doses reduce postoperative pain severity more than 1 mg/kg/h infusion doses in patients undergoing lumbar stabilization surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group who gets 1 mg/kg/min IV lidocaine infusion during surgery
Drug: Lidocaine
Group who gets 2 mg/kg/min IV lidocaine infusion during surgery
Drug: Lidocaine IV
Intravenous infusion rate of lidocaine is 2 mg/kg/min
Intravenous infusion rate of lidocaine is 1 mg/kg/min
Assessing Postoperative pain with the pain scoring system (Visual Pain Scale).
The primary endpoint was the evaluation and comparison of two different infusion doses (2 mg/kg/hr and 1 mg/kg/hr) of postoperative pain with the pain scoring system (Visual Pain Scale).
Time frame: 24 hours
Monitoring Intraoperative blood pressure
The secondary endpoint was to determine and compare the effect of two different infusion doses on intraoperative blood pressure
Time frame: 2 hours
Monitoring intraoperative heart rate
The secondary endpoint was to determine and compare the effect of two different infusion doses on intraoperative heart rate
Time frame: 2 hours
Started Feb 2023 (actual). Primary completion is estimated for Jan 2024, 11 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 11 months is close to that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lidocaine